Literature DB >> 34248216

COVID-19 outbreaks among isolated Amazonian indigenous people, Ecuador.

Aquiles R Henriquez-Trujillo1, Esteban Ortiz-Prado1, Ismar A Rivera-Olivero1, Nemonte Nenquimo2, Andrés Tapia3, Mitchell Anderson4, Tannya Lozada1, Miguel Angel Garcia-Bereguiain1.   

Abstract

Entities:  

Year:  2021        PMID: 34248216      PMCID: PMC8243033          DOI: 10.2471/BLT.20.283028

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


× No keyword cloud information.
By October 2020, Ecuador had more than 166 excess deaths per 100 000 population, becoming one of the countries with the highest number of coronavirus disease 2019 (COVID-19) related deaths.– Official data at the time of the study reported more than 170 000 confirmed COVID-19 cases and more than 8000 related deaths; however, these numbers are expected to be much higher. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnosis has mainly targeted large urban areas such as Guayaquil, Quito or Cuenca, the only cities where free testing is available through the National Institute of Public Health Research. Despite the institute’s efforts to improve testing capacity, no more than 3000 polymerase chain reaction (PCR) tests have been performed per day in Ecuador, for a population of 17 million. Here we describe the impact of COVID-19 on the neglected indigenous communities of the Ecuadorian Amazonia. The low testing capacity, urban location of laboratories and high prices (90–120 United States dollars) of PCR tests makes SARS-CoV-2 testing hard to access for rural and underserved communities, including traditionally neglected indigenous people, who represent an estimated 7% of the Ecuadorian population. Amazonian indigenous communities are highly vulnerable to public health threats such as COVID-19 because of their extreme isolation and the poor health infrastructure in the areas they inhabit. The Confederation of Indigenous Nationalities of the Ecuadorian Amazon reported outbreaks of COVID-19 from June to July 2020 in these communities. This nongovernmental organization contacted our research group at Universidad de Las Americas, a private academic institution, to deploy teams to provide medical assistance and SARS-CoV-2 testing by PCR.– The Waorani, Siona, Kichwa, Shuar and Kofan people, some of the most isolated groups in the area and often only accessible by boat or aeroplane, were included in this intervention from June to September 2020. We found COVID-19 outbreaks in 12 out of 14 the communities visited, with only two remaining SARS-CoV-2 free. A total of 769 individuals were tested (that is, most members from the communities included in the intervention) enrolled in the sampling. SARS-CoV-2 attack rates ranged from 30% to 90% in those communities, and the overall percentage of infected people was 49% (378/769). SARS-CoV-2 positivity, per ethnic group, was 46.0% (70/152) for Waoranis; 31.5% (40/127) for Sionas; 49.8% (124/249) for Kichwas; 54.9% (45/82) for Kofans; and 62.3% (99/159) for Shuars. We did not record any deaths during our visits. While community leaders said that some deaths were potentially related to COVID-19, the number of COVID-19 deaths is uncertain. COVID-19 outbreaks in the Amazonian indigenous communities are particularly worrying for the Tagaeri and Taromenane people, the last uncontacted groups of the Ecuadorian Amazonia at the Untouchable Zone of Yasuní National Park, where access is restricted due to the presence of uncontacted Amazonian tribes. These communities have some contact with the Waorani people. Our coordinated actions with Waorani leaders to report COVID-19 outbreaks in their communities supported the lawsuit against Ecuador’s President and Vice President, for having failed to provide these communities with protection against COVID-19. In a public statement during the lawsuit, Waorani leaders said that their actions were aimed at protecting their elders or Pikenani, as well as their uncontacted relatives. The Provincial Court of Pichincha recently ruled in favour of the Waorani people and required the Government of Ecuador to conduct SARS-CoV-2 tests and take action to contain the virus in Waorani territory. Today, SARS-CoV-2 testing capacities have not yet improved in Ecuador and COVID-19 vaccination programmes have been progressing slowly. Moreover, the effect of COVID-19 on the indigenous communities described in this study has been reported for other indigenous communities in Ecuador as well; they also have excess death rates due to COVID-19. We call on the Government of Ecuador to act to improve the court-mandated measures to protect the Waorani people, as well as all the Amazonian, Andean and Coastal ethnic groups. We also call on all governments in the continent to protect the indigenous people of the Americas against COVID-19.
  10 in total

1.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

2.  Localising an asset-based COVID-19 response in Ecuador.

Authors:  Irene Torres; Fernando Sacoto
Journal:  Lancet       Date:  2020-04-08       Impact factor: 79.321

3.  The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.

Authors: 
Journal:  Nat Microbiol       Date:  2020-03-02       Impact factor: 17.745

4.  Massive SARS-CoV-2 RT-PCR Testing on Rural Communities in Manabi Province (Ecuador) Reveals Severe COVID-19 Outbreaks.

Authors:  Esteban Ortiz-Prado; Aquiles R Henriquez-Trujillo; Ismar A Rivera-Olivero; Byron Freire-Paspuel; Alexander Paolo Vallejo-Janeta; Tannya Lozada; Miguel Angel Garcia-Bereguiain
Journal:  Am J Trop Med Hyg       Date:  2021-02-08       Impact factor: 2.345

5.  Analytical and clinical evaluation of a heat shock SARS-CoV-2 detection method without RNA extraction for N and E genes RT-qPCR.

Authors:  Alfredo Bruno; Domenica de Mora; Byron Freire-Paspuel; Angel S Rodriguez; Maria Belen Paredes-Espinosa; Maritza Olmedo; Martha Sanchez; Jennifer Romero; Michelle Paez; Manuel Gonzalez; Alberto Orlando; Miguel Angel Garcia-Bereguiain
Journal:  Int J Infect Dis       Date:  2021-06-21       Impact factor: 3.623

6.  Cotton-Tipped Plastic Swabs for SARS-CoV-2 RT-qPCR Diagnosis to Prevent Supply Shortages.

Authors:  Byron Freire-Paspuel; Patricio Vega-Mariño; Alberto Velez; Paulina Castillo; Eliana Elizabeth Gomez-Santos; Marilyn Cruz; Miguel Angel Garcia-Bereguiain
Journal:  Front Cell Infect Microbiol       Date:  2020-06-23       Impact factor: 5.293

7.  US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2.

Authors:  Xiaoyan Lu; Lijuan Wang; Senthilkumar K Sakthivel; Brett Whitaker; Janna Murray; Shifaq Kamili; Brian Lynch; Lakshmi Malapati; Stephen A Burke; Jennifer Harcourt; Azaibi Tamin; Natalie J Thornburg; Julie M Villanueva; Stephen Lindstrom
Journal:  Emerg Infect Dis       Date:  2020-05-15       Impact factor: 6.883

8.  Evaluation of nCoV-QS (MiCo BioMed) for RT-qPCR detection of SARS-CoV-2 from nasopharyngeal samples using CDC FDA EUA qPCR kit as a gold standard: An example of the need of validation studies.

Authors:  Byron Freire-Paspuel; Patricio Vega-Mariño; Alberto Velez; Paulina Castillo; Marilyn Cruz; Miguel Angel Garcia-Bereguiain
Journal:  J Clin Virol       Date:  2020-05-22       Impact factor: 3.168

9.  "One health" inspired SARS-CoV-2 surveillance: The Galapagos Islands experience.

Authors:  Byron Freire-Paspuel; Patricio Vega-Mariño; Alberto Velez; Paulina Castillo; Carlos Masaquiza; Ronald Cedeño-Vega; Tannya Lozada; Marilyn Cruz; Miguel Angel Garcia-Bereguiain
Journal:  One Health       Date:  2020-10-20

10.  "Sample pooling of RNA extracts to speed up SARS-CoV-2 diagnosis using CDC FDA EUA RT-qPCR kit".

Authors:  Byron Freire-Paspuel; Patricio Vega-Mariño; Alberto Velez; Marilyn Cruz; Miguel Angel Garcia-Bereguiain
Journal:  Virus Res       Date:  2020-09-24       Impact factor: 3.303

  10 in total
  4 in total

1.  Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.

Authors:  Nathália M S Sansone; Matheus N Boschiero; Manoela M Ortega; Isadora A Ribeiro; Andressa O Peixoto; Roberto T Mendes; Fernando A L Marson
Journal:  Lancet Reg Health Am       Date:  2022-01-07

2.  Diagnostic Performance of Seven Commercial COVID-19 Serology Tests Available in South America.

Authors:  Ismar A Rivera-Olivero; Aquiles R Henríquez-Trujillo; Nikolaos C Kyriakidis; Esteban Ortiz-Prado; Juan Carlos Laglaguano; Alexander Paolo Vallejo-Janeta; Tannya Lozada; Miguel Angel Garcia-Bereguiain
Journal:  Front Cell Infect Microbiol       Date:  2022-02-18       Impact factor: 5.293

3.  SARS-CoV-2 infection in free roaming dogs from the Amazonian jungle.

Authors:  Marlon Steven Zambrano-Mila; Byron Freire-Paspuel; Solon Alberto Orlando; Miguel Angel Garcia-Bereguiain
Journal:  One Health       Date:  2022-04-05

4.  Sustained COVID-19 community transmission and potential super spreading events at neglected afro-ecuadorian communities assessed by massive RT-qPCR and serological testing of community dwelling population.

Authors:  Alexander Paolo Vallejo-Janeta; Diana Morales-Jadan; Maria Belen Paredes-Espinosa; Barbara Coronel; Heberson Galvis; Hugo Renato Bone-Guano; Belen Amador Rodriguez; Guadalupe Gomez Abeledo; Byron Freire-Paspuel; Esteban Ortiz-Prado; Ismar Rivera-Olivero; Aquiles Rodrigo Henriquez-Trujillo; Tannya Lozada; Miguel Angel Garcia Bereguiain
Journal:  Front Med (Lausanne)       Date:  2022-08-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.